BLOOD GROUP FREQUENCY DISPARITIES BETWEEN PATIENTS AND HEALTHY BLOOD DONORS IN A TERTIARY CARE HOSPITAL: MYTH OR REALITY?
Main Article Content
Keywords
ABO, Blood group frequencies, Healthy blood donors, Patients, RhD
Abstract
ABO blood groups have been linked to various diseases, influenced by both environmental factors and genetics. Aim of this study was to investigate significant disparities in blood group frequencies between patients and healthy blood donors and to explore the underlying reasons for these differences. This cross-sectional retrospective study was done for a period of two years at a tertiary care centre in eastern India on patients and healthy blood donors. ABO and RhD blood groups were determined using column agglutination technique for blood donors and conventional test-tube technique for patients. Z-score was calculated to compare the two populations on the basis of blood groups. Chi-square test for independence was calculated to correlate the presence of A and B antigens with disease status of the populations. A p-value of <0.05 was considered statistically significant. Out of 75,817 participants, 31,586 (41.66%) were blood donors and 44,231 (58.34%) were patients. Most common blood group among both populations was B (blood donors=36.45%, patients= 37.64%), least common was AB (blood donors=8.88%, patients= 7.76%). Frequencies of all blood groups were almost similar in both populations. Correlation between RhD blood group and disease status of the populations was statistically significant. Result of comparison between only A antigen with only B antigen and the populations was statistically significant so was the presence of RhD antigen. Frequencies of blood groups and their associations with diseases in tertiary healthcare settings are vital for guiding clinical assessments and interventions, and optimizing blood stock management through targeted donor recruitment strategies.
References
2. Chen Z, Yang SH, Xu H, Li JJ. ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Scientific reports. 2016 Mar 18;6(1):23250.
3. Wu O, Bayoumi N, Vickers MA, Clark PA. ABO (H) blood groups and vascular disease: a systematic review and meta‐analysis. Journal of thrombosis and haemostasis. 2008 Jan 1;6(1):62-9.
4. George VT, Elston RC, Amos CI, Ward LJ, Berenson GS, Rao DC. Association between polymorphic blood markers and risk factors for cardiovascular disease in a large pedigree. Genetic epidemiology. 1987;4(4):267-75.
5. Paquette M, Dufour R, Baass A. ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia. Journal of Clinical Lipidology. 2018 Mar 1;12(2):383-9.
6. Shusterman M, Golub E, Mowrey WB, Broder A. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex. Lupus. 2018 Feb;27(2):319-26.
7. Lindqvist PG, Dahlback B. Carriership of Factor V Leiden and evolutionary selection advantage. Current Medicinal Chemistry. 2008 Jun 1;15(15):1541-4.
8. Trégouët, D.A., Heath, S., Saut, N., Biron-Andreani, C., Schved, J.F., Pernod, G., Galan, P., Drouet, L., Zelenika, D., Juhan-Vague, I. and Alessi, M.C., 2009. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood, The Journal of the American Society of Hematology, 113(21), pp.5298-5303.
9. Paré G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, Miletich JP, Ridker PM. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS genetics. 2008 Jul 4;4(7):e1000118.
10. Standards For Blood Banks & Blood Transfusion Services, National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India, New Delhi, 2007.
11. The Drug and Cosmetics Act, 1940 and the Drug and Cosmetics Rules, 1945, as amended up to 30th June, 2005. Schedule F. Part XIIB. Central Drugs Standard Control Organization. Director General of Health Services. Ministry of Health and Family Welfare. Government of India; 268–288. Available from URL: http://www.cdsco.nic.in/writereaddata/drugs&cosmeticact.pdf
12. Kapoor M, Agrawal D, Ravi S, Roy A, Subramanian SV, Guleria R. Missing female patients: an observational analysis of sex ratio among outpatients in a referral tertiary care public hospital in India. BMJ open. 2019 Aug 1;9(8):e026850.
13. Agnihotri N, Chaturvedi YM, Agnihotri A. Impact analysis of the national guidelines for blood donor selection in India: a single center study. Indian Journal of Hematology and Blood Transfusion. 2019 Oct;35(4):726-30.
14. Mondal B, Maiti S, Biswas BK, Ghosh D, Paul S. Prevalence of hemoglobinopathy, ABO and rhesus blood groups in rural areas of West Bengal, India. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2012 Aug;17(8):772.
15. Patidar GK, Dhiman Y. Distribution of ABO and Rh (D) Blood groups in India: A systematic review. ISBT science series. 2021 Feb;16(1):37-48.
16. Ranjan S, Khan MA, Kumar R, Das B, Singh N, Nayan N, Lahare S. Frequency of Rh and Kell antigens among blood donors: A retrospective analysis from a tertiary care center in Eastern India. Journal of Hematology and Allied Sciences. 2024 Feb 7;3(3):109-14.